Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/16/2/279/327341/mdi046.pdf
Reference14 articles.
1. Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer;Falkson;Cancer,1984
2. 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract;Harvey;J Clin Oncol,1984
3. Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas;Choi;Am J Clin Oncol,2000
4. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin;Ducreux;Ann Oncol,1998
5. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer;Glimelius;Ann Oncol,1996
Cited by 127 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches;Cancers;2024-02-16
2. Locoregional therapy combined with systemic therapy (LRT + ST) for unresectable and metastatic intrahepatic cholangiocarcinoma: a systematic review and meta-analysis;Radiology and Oncology;2023-11-30
3. NGAL and KIM-1 – early urinary biomarkers of nephrotoxicity mediated by cisplatin: Observational study;Journal of Modern Oncology;2022-04-30
4. Novel biomarkers for cholangiocarcinoma: how can it enhance diagnosis, prognostication, and investigational drugs? Part-1;Expert Opinion on Investigational Drugs;2021-10-03
5. Conversion surgery for initially unresectable extrahepatic biliary tract cancer;Annals of Hepato-Biliary-Pancreatic Surgery;2021-08-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3